Scorpius Holdings Inc. (OTCQB: SCPX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SCORPIUS HOLDINGS INC.

Scorpius Holdings Inc. (OTCQB: SCPX)
Listen to this Section


$0.00
N/A ( 0% ) 0.0K

Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. Scorpius offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities in San Antonio, TX. With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing.

Clinical Trial Pipeline Stages


Drug Name Stage
ANTHIM® (obiltoxaximab)DetailsAnthrax Approved
PTX-35 (TNFRSF25)DetailsSolid tumor/s, Cancer Failed
HS-130 (OX40L)DetailsSolid tumor/s, Cancer Failed
HS-110 (gp96 + CTAs)DetailsLung cancer, Non-small cell lung carcinoma, Cancer Failed

Market Data


Open $0.00
Previous Close $0.00
Volume 0.0K
Market Cap $0.09M
Day Range $0.00 - $0.00
52 Week Range $0.00 - $0.35
Shares Outstanding 61.14M
Change % 0%
Net Change N/A
Insider Ownership N/A
Exchange OTCQB
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -2,500,000.00

Date Type Amount Purchased Purchaser
2024-05-17 Sale -2500000.00 Wolf Jeffrey Alan

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Jul 23, 2025
8-k 8K-related 13 Jul 03, 2025
8-k 8K-related 13 Jun 23, 2025
8-k 8K-related 12 Jun 05, 2025
8-k 8K-related 13 Jun 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy